November 8, 2022

Christina Bucci-Rechtweg, MD

Dr. Bucci-Rechtweg graduated with a MD from the University of Rochester School of Medicine & Dentistry and was Residency trained in Pediatrics and Fellowship trained in Pediatric Critical Care Medicine at the State University of New York at Buffalo. She has over 20 years of pharmaceutical industry experience with roles in Clinical Development & Medical Affairs as well as Regulatory and Development Policy, where she was responsible for the oversight and registration of global clinical development programs.

In her career she has developed and implemented clinical programs as a Global Medical Director for pediatric and women’s health in phase II and III, including those with pediatric regulatory obligations in the EU and the United States, and is widely regarded for her negotiating skills in adult and pediatric drug development, as well as health policy and international regulatory consensus building.

Dr. Bucci-Rechtweg is actively involved in numerous external organizations advancing the regulatory and development environment for pediatric and maternal health globally, including the U.S. National Advisory Council for Child Health and Human Development, ICH Pediatric Standing Advisory Committee, ICH E11A Pediatric Extrapolation Expert Working Group, Critical Path Institute’s International Neonatal Consortium, EFGCP Children’s Medicines Working Party, the IQ Consortia’s Pediatric Clinical Pharmacology Leadership Group, HHS Task Force on Research in Pregnant Women & Lactating Women, as well as numerous professional societies and the trades. Christina is currently the Global Head for Pediatric and Maternal Health Policy at Novartis Pharmaceuticals Corporation.